Lipocine Inc (LPCN) stock is down -30.39% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives LPCN stock a score of 74 out of a possible 100.
That rank is primarily influenced by a fundamental score of 96. In addition to the average rating from Wall Street analysts, LPCN stock has a mean target price of 3. This means analysts expect the stock to increase 138.10% over the next 12 months. LPCN's rank also includes a long-term technical score of 87. The short-term technical score for LPCN is 39.
What's Happening with LPCN Stock Today
Lipocine Inc (LPCN) stock has gained 2.85% while the S&P 500 is higher by 0.83% as of 9:45 AM on Wednesday, Jul 15. LPCN is higher by $0.03 from the previous closing price of $1.23 on volume of 80,627 shares. Over the past year the S&P 500 is higher by 7.32% while LPCN is down -30.39%. LPCN lost -$0.51 per share in the over the last 12 months.
Click Here to get the full Stock Score Report on Lipocine Inc (LPCN) Stock.
